Soueidan et al. revealed that two fluorinated fructose derivatives (3-FDF and 1-FDAM) are efficiently transported into breast cancer cells via GLUT5, emphasizing GLUT5's central role in fructose-dependent tumor metabolism and potential cancer progression 139. The gene discussed is SLC2A5; the disease is neoplasm.